MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma

被引：4

作者：

Li, Huahui ^{[1
,2
,3
,4
]}

Li, Yuting ^{[1
,2
,3
,4
]}

Zhang, Ying ^{[1
,2
]}

Tan, Binbin ^{[1
,2
]}

Huang, Tuxiong ^{[1
,2
]}

Xiong, Jixian ^{[1
,2
]}

Tan, Xiangyu ^{[1
,2
]}

Ermolaeva, Maria A. A. ^{[3
]}

Fu, Li ^{[1
,2
]}

机构：

[1] Shenzhen Univ Hlth Sci Ctr, Guangdong Prov Key Lab Reg Immun & Dis, Dept Pharmacol, Shenzhen, Peoples R China

[2] Shenzhen Univ Hlth Sci Ctr, Shenzhen Univ Int Canc Ctr, Shenzhen, Peoples R China

[3] Leibniz Inst Aging Fritz Lipmann Inst, Grp Homeostasis & Stress Tolerance, Jena, Germany

[4] Shenzhen Univ Sch Med, Shenzhen Univ Friedrich Schiller Univ Jena Joint, Shenzhen, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

基金：

国家重点研发计划; 中国国家自然科学基金;

关键词：

MAPK10; ICAM1; hepatocellular carcinoma; tumor microenvironment; immune cells; immune surveillance; tumor infiltration lymphocytes; INTERCELLULAR-ADHESION MOLECULE-1; REGULATORY ELEMENTS; DOWN-REGULATION; ICAM-1; CELLS; TRANSCRIPTION; ACTIVATION; MIGRATION; SURVIVAL; THERAPY;

D O I：

10.3389/fonc.2021.687371

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatocellular carcinoma (HCC) remains a devastating malignancy worldwide due to lack of effective therapy. The immune-rich contexture of HCC tumor microenvironment (TME) makes this tumor an appealing target for immune-based therapies; however, the immunosuppressive TME is still a major challenge for more efficient immunotherapy in HCC. Using bioinformatics analysis based on the TCGA database, here we found that MAPK10 is frequently down-regulated in HCC tumors and significantly correlates with poor survival of HCC patients. HCC patients with low MAPK10 expression have lower expression scores of tumor infiltration lymphocytes (TILs) and stromal cells in the TME and increased scores of tumor cells than those with high MAPK10 expression. Further transcriptomic analyses revealed that the immune activity in the TME of HCC was markedly reduced in the low-MAPK10 group of HCC patients compared to the high-MAPK10 group. Additionally, we identified 495 differentially expressed immune-associated genes (DIGs), with 482 genes down-regulated and 13 genes up-regulated in parallel with the decrease of MAPK10 expression. GO enrichment and KEGG pathway analyses indicated that the biological functions of these DIGs included cell chemotaxis, leukocyte migration and positive regulation of the response to cytokine-cytokine receptor interaction, T cell receptor activation and MAPK signaling pathway. Protein-protein interaction (PPI) analyses of the 495 DIGs revealed five potential downstream hub genes of MAPK10, including SYK, CBL, VAV1, LCK, and CD3G. Several hub genes such as SYK, LCK, and VAV1 could respond to the immunological costimulatory signaling mediated by the transmembrane protein ICAM1, which was identified as a down-regulated DIG associated with low-MAPK10 expression. Moreover, ectopic overexpression or knock-down of MAPK10 could up-regulate or down-regulate ICAM1 expression via phosphorylation of c-jun at Ser63 in HCC cell lines, respectively. Collectively, our results demonstrated that MAPK10 down-regulation likely contributes to the immunosuppressive TME of HCC, and this gene might serve as a potential immunotherapeutic target and a prognostic factor for HCC patients.

引用

页数：21